Mehri S McKellar

发表

Health Care Utilization Behaviors Predict Disengagement From HIV Care: A Latent Class Analysis

J. Stout, M. Clement, N. L. Okeke, 2018, Open forum infectious diseases.

Awareness and acceptability of HIV pre-exposure prophylaxis (PrEP) among students at two historically Black universities (HBCU): a cross-sectional survey

John T. Mitchell, N. L. Okeke, Mehri S McKellar, 2021, BMC Public Health.

History of AIDS in HIV-Infected Patients Is Associated With Higher In-Hospital Mortality Following Admission for Acute Myocardial Infarction and Stroke.

V. Fowler, C. Hicks, J. Federspiel, 2016, The Journal of infectious diseases.

The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes.

M. Samore, A. Ronald, M. Sande, 2007, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial

F. J. McClernon, John T. Mitchell, A. Kashuba, 2018, JMIR mHealth and uHealth.

Public Awareness of HIV Pre-Exposure Prophylaxis in Durham, North Carolina

G. Samsa, A. Seña, B. Johnston, 2019, North Carolina Medical Journal.

HIV Preexposure Prophylaxis Implementation at Local Health Departments: A Statewide Assessment of Activities and Barriers

Sarah K. Rhea, A. Seña, C. Hurt, 2017, Journal of acquired immune deficiency syndromes.

Sexual orientation differences in HIV testing motivation among college men

G. Samsa, Mehri S McKellar, D. Kort, 2017, Journal of American college health : J of ACH.

Canary in the Coal Mine? Transmitted Mutations Conferring Resistance to All Integrase Strand Transfer Inhibitors in a Treatment-Naive Patient

C. Hurt, N. L. Okeke, Mehri S McKellar, 2018, Open forum infectious diseases.

Diagnosing HIV infection in primary care settings: missed opportunities.

G. Samsa, C. Hicks, Mehri S McKellar, 2013, AIDS patient care and STDs.

Perspectives of Black women in the United States on salon-based intervention to promote the uptake of pre-exposure prophylaxis (PrEP) for HIV.

Danielle Myers, Schenita D. Randolph, Mehri S McKellar, 2021, Journal of clinical nursing.

Antiretroviral therapy for HIV-1 infected adolescents in Uganda: Assessing the impact on growth and sexual maturation

P. Musoke, A. Ronald, M. Javanbakht, 2008, Journal of Pediatric Infectious Diseases.

Feasibility, Acceptability, and Preliminary Efficacy of a Gamified Mobile Health Contingency Management Intervention for PrEP Adherence Among Black MSM

F. J. McClernon, John T. Mitchell, A. Kashuba, 2022, AIDS and Behavior.

Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States

Sheri L. Towe, C. Meade, Mehri S McKellar, 2020, AIDS and Behavior.

HIV care and treatment for children in resource-limited settings

R. Colebunders, Mehri S McKellar, S. Callens, 2008, Expert review of anti-infective therapy.

Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation

C. Meade, A. Corneli, B. Perry, 2022, Harm Reduction Journal.

Case Report: Reversal of Integrase Inhibitor– and Tenofovir Alafenamide–Related Weight Gain After Switching Back to Efavirenz/Emtricitabine/Tenofovir DF

F. Pohlman, Mehri S McKellar, K. McGee, 2021, Open forum infectious diseases.

Safety of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis: an open-label, single-arm, multicentre, phase 3b trial.

M. Das, J. Lelièvre, J. Slim, 2019, The lancet. HIV.

1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis

D. Asmuth, J. Slim, J. Eron, 2020, Open Forum Infectious Diseases.

Role of the CD4 count in HIV management

R. Colebunders, Mehri S McKellar, J. Griensven, 2010 .

Pediatric HIV infection: the state of antiretroviral therapy

R. Colebunders, Mehri S McKellar, S. Callens, 2008, Expert review of anti-infective therapy.

False-positivity of HIV-2 immunoblots in a cohort of elite suppressors infected with HIV-1.

H. Khanlou, Mehri S McKellar, Pam Jongthavorn, 2008, Journal of acquired immune deficiency syndromes.

Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022

Cameron R. Wolfe, D. A. Wheeler, P. Alapat, 2022, MMWR. Morbidity and mortality weekly report.

An educational initiative in response to identified PrEP prescribing needs among PCPs in the Southern U.S.

G. Samsa, M. Clement, N. L. Okeke, 2018, AIDS care.

Racial Differences in Change in Physical Functioning in Older Male Veterans with HIV.

Kathleen M. Akgün, G. Fillenbaum, S. Crystal, 2019, AIDS research and human retroviruses.

Low Levels of Physical Activity Among Older Persons Living with HIV/AIDS Are Associated with Poor Physical Function.

F. Lobelo, C. del Rio, M. Morey, 2018, AIDS research and human retroviruses.

Fatal Granulomatous Acanthamoeba Encephalitis Mimicking a Stroke, Diagnosed by Correlation of Results of Sequential Magnetic Resonance Imaging, Biopsy, In Vitro Culture, Immunofluorescence Analysis, and Molecular Analysis

G. Booton, P. Fuerst, G. Visvesvara, 2006, Journal of Clinical Microbiology.

Understanding Retention in Pre-Exposure Prophylaxis Care in the South: Insights from an Academic HIV Prevention Clinic

M. Borges, N. L. Okeke, Mehri S McKellar, 2022, AIDS research and human retroviruses.

PrEP Outcomes in an Urban Community in North Carolina: Discontinuation of Care and Sexually Transmitted Infections.

H. Chakraborty, A. Seña, M. Clement, 2020, Sexually transmitted diseases.

Seroconversion on preexposure prophylaxis: a case report with segmental hair analysis for timed adherence determination

J. Thaden, M. Gandhi, C. Hurt, 2018, AIDS.

Partnerships Between a University-Affiliated Clinic and Community-Based Organizations to Reach Black Men Who Have Sex With Men for PrEP Care

A. Seña, M. Clement, A. Corneli, 2017, Journal of acquired immune deficiency syndromes.

A survey of South Carolina pharmacists' readiness to prescribe human immunodeficiency virus pre‐exposure prophylaxis

A. Corneli, Kyle Endres, N. L. Okeke, 2023, Journal of the American College of Clinical Pharmacy : JACCP.

Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

J. Routy, D. Margolis, D. Asmuth, 2016, Journal of acquired immune deficiency syndromes.

Diminished physical function in older HIV-infected adults in the Southeastern U.S. despite successful antiretroviral therapy

C. Pieper, M. Morey, K. Huffman, 2017, PloS one.

Acute HIV-1 infection in the Southeastern United States: a cohort study.

D. Margolis, G. Ferrari, C. Hurt, 2013, AIDS research and human retroviruses.

Impact of Policy Change on Access to Medication for Opioid Use Disorder in Primary Care

H. Chakraborty, K. Link, Yujung Choi, 2023, Southern medical journal.

Efficacy, pharmacokinetics and neurocognitive performance of dual, NRTI-sparing antiretroviral therapy in acute HIV-infection.

D. Margolis, G. Ferrari, K. Robertson, 2020, AIDS.

Testing for HIV infection in the emergency departments of 2 hospitals in the Southeastern United States

C. Gerardo, C. Hicks, Mehri S McKellar, 2020, Journal of the American College of Emergency Physicians open.

Development and validation of an electronic medical record (EMR)-based computed phenotype of HIV-1 infection

Joseph E. Lucas, Matthew Phelan, Nigel B. Neely, 2018, J. Am. Medical Informatics Assoc..

HIV Testing in the Emergency Department

C. Hicks, Mehri S McKellar, 2009 .

Title Dendritic cell immunotherapy for HIV-1 infection using autologous HIV-1 RNA : A randomized , double-blind , placebo-controlled clinical trial Permalink

J. Routy, D. Margolis, D. Asmuth, 2022 .

Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide–Based Regimens

C. Katlama, R. Batterham, S. Scholten, 2023, Open forum infectious diseases.

Perceptions on HIV Pre-Exposure Prophylaxis Among Urgent Care Clinicians in the Southern United States

Kyle Endres, N. L. Okeke, Mehri S McKellar, 2022, Current HIV research.

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability

D. Margolis, G. Ferrari, J. Eron, 2016, AIDS.

Provider perspectives on screening and treatment for opioid use disorder and mental health in HIV care: A qualitative study

Mehri S McKellar, Elena Wilson, Hillary Chen, 2024, PLoS ONE.

Leveraging Policy Changes Made in Response to COVID-19 to Advance Telehealth and Novel Treatment Approaches for People Who Use Opioids: Qualitative Perspectives From Two Rural North Carolina Counties.

Hilary Campbell, P. Gulur, Amanda Nelli, 2023, North Carolina medical journal.

Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study

Mehri S McKellar, Lauren Kestner, Nidhi Sachdeva, 2024, Harm reduction journal.